AZN vs OWL · P/E 28, $288.38B cap vs P/E 79, rev $275.1M
AstraZeneca PLC (AZN) versus Blue Owl Capital Inc (OWL) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Blue Owl Capital Inc (OWL) is a asset management company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported OWL revenue for 2026-06-30 was $275.1M. Net income was $26.9M. Revenue was up 99.3% from 2026-03-31 to 2026-06-30. OWL currently screens at market cap $14.82B and trailing P/E 79.2.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. OWL currently screens at market cap $14.82B and trailing P/E 79.2.
Not investment advice. Open the AZN and OWL stock pages for the full models.
Not investment advice.